MHC-2 TRZ | Tirzepatide 60mg

GLP-1/GIP Dual Receptor Agonist

$249.99$239.99

MHC-2 TRZ (Tirzepatide) 60mg is the ultimate, maximum-volume option in the MHC-2 TRZ product line, engineered exclusively for elite research institutions, large-scale collaborative programs, and high-throughput laboratory environments that demand the highest possible compound availability without compromise. This 60mg variant represents the pinnacle of the Tirzepatide research compound offering from Mile High Compounds, delivering an exceptional supply of pharmaceutical-grade lyophilized Tirzepatide to support the most ambitious, expansive, and complex metabolic research programs currently being conducted in the scientific community.

For research teams operating at the highest levels of metabolic science, the MHC-2 TRZ 60mg vial eliminates the logistical challenges of frequent restocking, ensures absolute compound consistency across all experimental arms, and provides the freedom to design bold, large-scale research programs without the constraints of limited supply. Tirzepatide's revolutionary dual engagement of the GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-dependent Insulinotropic Polypeptide) receptors has firmly established it as one of the most important and widely studied peptide compounds in contemporary metabolic research, and the 60mg variant ensures that the most demanding research environments have everything they need to explore its full scientific potential.

This variant is the definitive choice for principal investigators, research directors, and institutional procurement teams seeking the most cost-effective, high-volume solution for sustained, uninterrupted Tirzepatide research at the highest levels of scientific rigor and experimental complexity.


Research Applications:

The MHC-2 TRZ 60mg variant is purpose-built for the most demanding, high-volume research environments and the most ambitious experimental frameworks in metabolic science, including:

  • Elite High-Throughput Research Programs — supporting large-scale, high-frequency experimental workflows that require consistent, uninterrupted access to substantial volumes of high-purity Tirzepatide across multiple simultaneous research tracks

  • Comprehensive Multi-Site Collaborative Studies — providing a centralized, high-volume compound supply for multi-institutional research collaborations requiring absolute consistency in compound quality, concentration, and availability across all participating sites and investigator teams

  • Extended Multi-Year Longitudinal Research — enabling ambitious long-duration research programs that track the full spectrum of metabolic, hormonal, and cellular changes associated with sustained dual GLP-1 and GIP receptor engagement over extended experimental timelines

  • Advanced Pancreatic & Beta-Cell Research — conducting deep, multi-phase investigations into the long-term effects of dual incretin receptor activation on pancreatic beta-cell preservation, insulin biosynthesis regulation, and glucose-stimulated insulin secretion dynamics across diverse research models

  • Comprehensive Adipose Tissue & Lipid Biology — exploring the full depth of Tirzepatide's influence on adipose tissue biology, including white and brown adipose tissue remodeling, lipogenesis inhibition, lipolysis acceleration, and systemic lipid panel regulation across multiple concurrent research groups

  • Systems-Level Metabolic Network Analysis — utilizing the generous compound volume to map the complete systems-level impact of dual incretin receptor agonism on interconnected metabolic networks, including glucose metabolism, lipid homeostasis, energy expenditure, hormonal signaling, and neurological appetite regulation simultaneously

  • Pharmacokinetic & Receptor Binding Studies — conducting detailed pharmacokinetic profiling, receptor binding affinity studies, and dose-response characterization across a wide range of compound concentrations, requiring large volumes to support the full breadth of analytical work

  • Biomarker Discovery & Pathway Validation — supporting large-scale omics studies, biomarker discovery programs, and signaling pathway validation experiments that require substantial compound volumes to generate statistically meaningful and scientifically reproducible datasets across multiple experimental replicates

  • Institutional Training & Research Development Programs — providing research institutions and academic departments with a sufficient compound supply to support both active research programs and the training of emerging research scientists in advanced peptide handling, experimental design, and metabolic research methodologies


Specifications:

Detail

Info

Product Code

MHC-2 TRZ

Active Compound

Tirzepatide

Form

Lyophilized Powder

Vial Size

60mg in a 3ml vial

Available Sizes

10mg, 30mg, 60mg

Storage

Cool, dry environment; Reconstituted: 2°C–8°C

Purity

≥99%

Recommended Use

In Vitro Research & Educational Purposes Only


Intended Use: This compound is offered solely for in vitro laboratory research. It is not intended for diagnostic, therapeutic, or clinical use in humans or animals. Not for dietary, cosmetic, or veterinary applications. This product has not been evaluated by the FDA or any medical body.


Disclaimer: All information provided is strictly educational. No claim of efficacy or safety is made. Buyers assume full responsibility for ensuring proper use under federal and local research guidelines.


Terms of Sale: By purchasing from Mile High Compounds, you affirm that you are a qualified researcher with the experience to safely handle and store research materials. All sales are final. The supplier is not liable for any misuse, misrepresentation, or unintended outcomes related to this product.